Search
for
Sort by
Research 871–900 of 1000+
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Assessment of vitamin D levels in patients with alopecia areata: a case-control study in a Tertiary Care Hospital in North India
- JAK Inhibitors in the Treatment of Alopecia Areata: Efficacy, Safety, and Long-term Outcomes
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Analyse trichoskopischer Bilder mit tiefen neuronalen Netzen zur Diagnose und Aktivitätsbewertung von Alopecia areata – eine retrospektive Studie
- A Comparative Study of the Therapeutic Effects of Intralesional Triamcinolone Acetonide and Platelet-Rich Plasma in Alopecia Areata at a Tertiary Health-Care Centre
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Molecular Predictors of Ritlecitinib Efficacy in Alopecia Areata: Role of JAK3-Dependent Inflammation and Follicular Integrity
- Knowledge, attitudes, and practices toward disease management among alopecia areata patients
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- 0282 Effect of systemic immunomodulators on incidence of alopecia areata: A retrospective cohort study
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- BH08 Unprovoked pulmonary emboli in a patient with alopecia areata treated with ritlecitinib: a case report
- Granulomatous Alopecia Areata: A Rare Report With a Review
- Baricitinib regrows hair in adolescents with alopecia areata
- Assessment of miR-19b-3p, miR-182-5p, and miR-155-5p expression and its relationship with alopecia areata severity
- 52309 Association of venous thromboembolism in patients with alopecia areata
- LB1040 Machine learning-based predictive model with routine blood work identifies moderate-severe alopecia areata
- LB892 Assessing the risk of alopecia areata development in patients with seasonal and food allergies: a matched population-level analysis
- LB923 A matched cohort study evaluating the risk of keloid development in alopecia areata patients
- Comparative efficacy of topical calcipotriol and tacrolimus in alopecia areata: A prospective trial
- Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Efficacy of Topical Clobetasol Propionate 0.05% Ointment and Topical Tacrolimus 0.1% Ointment in Treatment of Alopecia Areata.: RCT
- A case control study of serum vitamin D levels in alopecia areata
- Combination of topical anthralin and calcipotriene in alopecia areata: A discussion of the mechanisms of action
- 272 Dupilumab treatment in children with alopecia areata: A real-world, single-center observational study
- ISID0197 - Quantitative analysis of hair loss in mice utilizing imageJ improves the efficacy evaluation of alopecia areata induction in the C3H/HeJ mouse model